Prescription drug · ANDA
Bexarotene NDC 0378-6955
Bexarotene 75 mg/1 · Capsule, Liquid filled · Oral · Mylan Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0378-6955-01 | 00378695501 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0378-6955-01)Marketed from Jul 9, 2015 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Bexarotene
- Generic name (nonproprietary)
- bexarotene
- Active ingredients
- Bexarotene — 75 mg/1
- Dosage form
- Capsule, Liquid filled
- Route
- Oral
- Labeler
- Mylan Pharmaceuticals Inc.NDC labeler code 0378
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203174
- Marketing start
- Listing expires
- Other FDA classes
- Retinoids (Chemical structure)
- Identifiers
- Product ID 0378-6955_6c9b41f4-421f-4ebf-8219-b68e68f75574SPL ID 6c9b41f4-421f-4ebf-8219-b68e68f75574
- Pharmacologic class
- Retinoid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400378695501followed by a unit qualifier and the quantityPackage 00378-6955-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 0378-6955
- What is NDC 0378-6955?
- 0378-6955 is the product NDC for Bexarotene, Bexarotene 75 mg/1 capsule, liquid filled, listed with the FDA by Mylan Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Bexarotene.
- What is the active ingredient?
- Bexarotene.
- Who is the labeler?
- Mylan Pharmaceuticals Inc., NDC labeler code 0378. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Bexarotene?
- 7 other product NDCs are listed under this name. See all Bexarotene NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Bexarotene products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Bexarotene | Bexarotene 75 mg/1 | CapsuleOral | Camber Pharmaceuticals, Inc. | 31722-380 | 31722-0380-01 |
| Bexarotene | Bexarotene 75 mg/1 | CapsuleOral | AvKARE | 42291-072 | 42291-0072-01 |
| Bexarotene | Bexarotene 10 mg/g | GelTopical | Amneal Pharmaceuticals NY LLC | 69238-2088 | 69238-2088-06 |
| bexarotene | Bexarotene 75 mg/1 | Capsule, Liquid filledOral | Actavis Pharma, Inc. | 0591-2832 | 00591-2832-01 |
| Bexarotene | Bexarotene 75 mg/1 | CapsuleOral | Amneal Pharmaceuticals NY LLC | 69238-1250 | 69238-1250-01 |
| Bexarotene | Bexarotene 75 mg/1 | CapsuleOral | Upsher-Smith Laboratories, Inc. | 0832-0285 | 00832-0285-00 |
| Bexarotene | Bexarotene 75 mg/1 | Capsule, Liquid filledOral | ANI Pharmaceuticals, Inc. | 43975-315 | 43975-0315-10 |